Healthcare provider profile · identity verified

David Bradley Beckstead, MD

Allopathic & Osteopathic Physicians|Family Medicine · PRESTON, ID · NPI 1801909122

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show David Bradley Beckstead, MD received $85.17 in general payments during 2025 across 5 reported records.

ABBVIE INC. accounted for 61.1% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro, Vraylar.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Creon by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 49 claims for Synthroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Vraylar by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 54 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$85.17

5 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$52.06	61.1%	3	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$33.11	38.9%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$85.17	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$33.11	2	2025
Source payment records 2025-01-23 · Lilly USA, LLC · $16.08 · Open Payments source 2025-02-13 · Lilly USA, LLC · $17.03 · Open Payments source
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$33.11	2	2025
Source payment records 2025-01-23 · Lilly USA, LLC · $16.08 · Open Payments source 2025-02-13 · Lilly USA, LLC · $17.03 · Open Payments source
VRAYLAR Normalized: vraylar	Drug	ABBVIE INC.	$32.11	2	2025
Source payment records 2025-03-24 · ABBVIE INC. · $18.45 · Open Payments source 2025-05-19 · ABBVIE INC. · $13.66 · Open Payments source
QULIPTA Normalized: qulipta	Drug	ABBVIE INC.	$19.95	1	2025
Source payment records 2025-06-16 · ABBVIE INC. · $19.95 · Open Payments source
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$19.95	1	2025
Source payment records 2025-06-16 · ABBVIE INC. · $19.95 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
MOUNJARO mounjaro	2025	Mounjaro	2024	54 Beneficiary count suppressed	exact normalized	Medicare Part D
VRAYLAR vraylar	2025	Vraylar	2024	24 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	CREON open payments reported associated product	CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608	Creon · 2024 Exact normalized brand match · 1 Part D row	21	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	49	12
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	VRAYLAR open payments reported associated product	CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550	Vraylar · 2024 Exact normalized brand match · 1 Part D row	24	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	54	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	37	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	873	191
Omeprazole	Omeprazole	745	187
Losartan Potassium	Losartan Potassium	744	186
Atorvastatin Calcium	Atorvastatin Calcium	530	145
Gabapentin	Gabapentin	506	106
Metoprolol Succinate	Metoprolol Succinate	445	120
Metformin Hcl	Metformin Hcl	403	101
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	401	83
Tramadol Hcl	Tramadol Hcl	387	85
Potassium Chloride	Potassium Chloride	374	82
Furosemide	Furosemide	372	86
Zolpidem Tartrate	Zolpidem Tartrate	357	49
Amlodipine Besylate	Amlodipine Besylate	346	92
Azithromycin	Azithromycin	331	255
Eliquis	Apixaban	329	52
Tamsulosin Hcl	Tamsulosin Hcl	318	83
Lisinopril	Lisinopril	311	76
Prednisone	Prednisone	297	141
Pantoprazole Sodium	Pantoprazole Sodium	289	74
Escitalopram Oxalate	Escitalopram Oxalate	274	62
Clonazepam	Clonazepam	272	37
Alprazolam	Alprazolam	267	52
Warfarin Sodium	Warfarin Sodium	245	59
Methylprednisolone	Methylprednisolone	238	192
Pregabalin	Pregabalin	238	42
Meloxicam	Meloxicam	222	57
Finasteride	Finasteride	219	59
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	219	58
Lorazepam	Lorazepam	215	35
Celecoxib	Celecoxib	213	56
Carvedilol	Carvedilol	205	41
Simvastatin	Simvastatin	195	51
Allopurinol	Allopurinol	191	58
Metoprolol Tartrate	Metoprolol Tartrate	191	45
Hydrochlorothiazide	Hydrochlorothiazide	180	45
Pioglitazone Hcl	Pioglitazone Hcl	175	47
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	145	39
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	141	33
Spironolactone	Spironolactone	139	37
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	128	106
Trazodone Hcl	Trazodone Hcl	128	32
Ciprofloxacin Hcl	Ciprofloxacin Hcl	124	101
Sertraline Hcl	Sertraline Hcl	120	29
Solifenacin Succinate	Solifenacin Succinate	116	28
Estradiol	Estradiol	115	27
Ropinirole Hcl	Ropinirole Hcl	113	21
Duloxetine Hcl	Duloxetine Hcl	112	20
Ibuprofen	Ibuprofen	110	31
Fluticasone Propionate	Fluticasone Propionate	107	28
Citalopram Hbr	Citalopram Hydrobromide	103	22
Fluoxetine Hcl	Fluoxetine Hcl	100	25
Albuterol Sulfate Hfa	Albuterol Sulfate	99	31
Clopidogrel	Clopidogrel Bisulfate	99	29
Memantine Hcl	Memantine Hcl	98	18
Triamcinolone Acetonide	Triamcinolone Acetonide	93	67
Montelukast Sodium	Montelukast Sodium	90	24
Fluconazole	Fluconazole	88	45
Rosuvastatin Calcium	Rosuvastatin Calcium	87	23
Xarelto	Rivaroxaban	86	16
Lantus	Insulin Glargine,hum.Rec.Anlog	85	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	84	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	82	16
Amitriptyline Hcl	Amitriptyline Hcl	81	20
Methenamine Hippurate	Methenamine Hippurate	81	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	78	52
Alendronate Sodium	Alendronate Sodium	72	24
Cephalexin	Cephalexin	72	40
Digoxin	Digoxin	72	15
Eszopiclone	Eszopiclone	72	suppressed
Clonidine Hcl	Clonidine Hcl	71	14
Risperidone	Risperidone	71	12
Amoxicillin	Amoxicillin	66	46
Quetiapine Fumarate	Quetiapine Fumarate	65	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	62	34
Glipizide Er	Glipizide	62	15
Ozempic	Semaglutide	61	15
Hydralazine Hcl	Hydralazine Hcl	58	11
Olanzapine	Olanzapine	56	suppressed
Metformin Hcl Er	Metformin Hcl	55	13
Mounjaro	Tirzepatide	54	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	53	30
Levetiracetam	Levetiracetam	53	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	53	34
Diazepam	Diazepam	52	suppressed
Bupropion Xl	Bupropion Hcl	51	13
Testosterone Cypionate	Testosterone Cypionate	51	19
Atenolol	Atenolol	50	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	49	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	suppressed
Synthroid	Levothyroxine Sodium	49	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	36
Sucralfate	Sucralfate	47	12
Cholestyramine Light	Cholestyramine	45	17
Januvia	Sitagliptin Phosphate	44	suppressed
Oxycodone Hcl	Oxycodone Hcl	44	suppressed
Glimepiride	Glimepiride	43	14
Oxybutynin Chloride	Oxybutynin Chloride	43	suppressed
Ezetimibe	Ezetimibe	42	12
Carbidopa-Levodopa	Carbidopa/Levodopa	41	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Acyclovir	Acyclovir	40	11
Esomeprazole Magnesium	Esomeprazole Magnesium	40	12
Ventolin Hfa	Albuterol Sulfate	40	11
Trimethoprim	Trimethoprim	39	suppressed
Amiodarone Hcl	Amiodarone Hcl	38	15
Triazolam	Triazolam	38	suppressed
Propranolol Hcl	Propranolol Hcl	37	11
Trulicity	Dulaglutide	37	suppressed
Aripiprazole	Aripiprazole	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	suppressed
Cartia Xt	Diltiazem Hcl	35	17
Glyburide	Glyburide	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	11
Dicyclomine Hcl	Dicyclomine Hcl	33	11
Fenofibrate	Fenofibrate	32	suppressed
Methotrexate	Methotrexate Sodium	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Fentanyl	Fentanyl	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Ramipril	Ramipril	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Latanoprost	Latanoprost	28	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	28	suppressed
Topiramate	Topiramate	28	suppressed
Cholestyramine	Cholestyramine (With Sugar)	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	18
Novolog Flexpen	Insulin Aspart	26	suppressed
Ondansetron Odt	Ondansetron	26	17
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Baclofen	Baclofen	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Modafinil	Modafinil	25	suppressed
Relistor	Methylnaltrexone Bromide	25	suppressed
Temazepam	Temazepam	25	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Famotidine	Famotidine	24	suppressed
Glipizide	Glipizide	24	suppressed
Novolog	Insulin Aspart	24	suppressed
Vraylar	Cariprazine Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Levofloxacin	Levofloxacin	23	18
Metolazone	Metolazone	23	suppressed
Tresiba Flextouch U-200	Insulin Degludec	23	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	15
Creon	Lipase/Protease/Amylase	21	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	21	suppressed
Nystatin	Nystatin	21	12
Premarin	Estrogens, Conjugated	21	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	19	suppressed
Metronidazole	Metronidazole	19	16
Myrbetriq	Mirabegron	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Mupirocin	Mupirocin	18	11
Naproxen	Naproxen	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Linzess	Linaclotide	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	17	suppressed
Fluocinonide	Fluocinonide	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Nitroglycerin	Nitroglycerin	16	13
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Pacerone	Amiodarone Hcl	15	suppressed
Sulfasalazine	Sulfasalazine	15	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	13
Rivastigmine	Rivastigmine Tartrate	14	suppressed
Valsartan	Valsartan	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Asa-Butalb-Caffeine-Codeine	Codeine/Butalbital/Asa/Caffein	13	suppressed
Cefdinir	Cefdinir	13	11
Junel Fe	Norethindrone-E.Estradiol-Iron	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Humalog	Insulin Lispro	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$85.17 · 5 records	ABBVIE INC.	MOUNJARO, QULIPTA, UBRELVY, VRAYLAR, ZEPBOUND	7	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Mounjaro play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error